Moderna, Merck cancer vaccine with Keytruda improved survival in trial

Moderna, Merck cancer vaccine with Keytruda improved survival in trial

Moderna and Merck released more positive three-year data Monday on their experimental vaccine, given to patients with the most deadly form of skin cancer in combination with the therapy Keytruda. The vaccine together with Merck’s Keytruda improved survival and showed long-lasting efficacy in a midstage study in patients with a deadly form of skin cancer. … Read more

Pfizer, Merck, J&J to release cancer drug data

Pfizer, Merck, J&J to release cancer drug data

Attendees walk through the lobby at the American Society of Clinical Oncology annual meeting in Chicago. Tim Boyle | Bloomberg | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! This is Annika, and I’ll be on the ground at the American … Read more

Wells Fargo CEO talks up reasons to love the stock — plus, why the market drop

Wells Fargo CEO talks up reasons to love the stock — plus, why the market drop

Every weekday, the CNBC Investing Club with Jim Cramer releases the Homestretch — an actionable afternoon update, just in time for the last hour of trading on Wall Street. Market pressure : The major stock benchmarks were moving lower Wednesday, with the Dow getting the worst of it again. Adding pressure on equities, bond yields … Read more

What Nvidia must deliver in earnings this week to remain AI king

What Nvidia must deliver in earnings this week to remain AI king

It’s all about to happen. But until it happens, then no money should be made waiting for it. We have to see its success to invest in it. Otherwise, the heck with it. There. That had been the bear case against artificial intelligence, generative AI, accelerated computing and large language models (LLMs), all the essential … Read more

Eli Lilly (LLY) says it can overcome high-quality problem of too much demand

Eli Lilly (LLY) says it can overcome high-quality problem of too much demand

Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and Zepbound, outstrips supply. Revenue in the three months ended March … Read more

Merck (MRK) earnings Q1 2024

Merck (MRK) earnings Q1 2024

Exterior view of the entrance to Merck headquarters on February 05, 2024 in Rahway, New Jersey. Spencer Platt | Getty Images Merck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as it posted strong sales of its blockbuster cancer drug Keytruda and vaccine products. The pharmaceutical giant also raised and narrowed its … Read more

Earnings from Tesla, Merck and Big Tech

Earnings from Tesla, Merck and Big Tech

CNBC Investing Club with Jim Cramer Rob Kim | NBCUniversal CNBC’s Jim Cramer on Friday noted that major quarterly results from players like Verizon, Meta, Microsoft and Alphabet will be coming next week, but he zeroed in on the importance of the Personal Consumption Expenditures index because it is the real gauge of inflation. Cramer said the … Read more

FDA approves Merck drug sotatercept for rare, deadly lung condition

FDA approves Merck drug sotatercept for rare, deadly lung condition

The Food and Drug Administration on Tuesday approved a drug from Merck designed to treat a progressive and life-threatening lung condition in a win for both the drugmaker and for patients suffering from the rare disease. The agency greenlighted the therapy, which will be marketed as Winrevair, for adults with pulmonary arterial hypertension. The decision … Read more

First NASH liver disease drug is here, more coming

First NASH liver disease drug is here, more coming

3D Illustration of a human liver organ. magicmine | iStock | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! Millions of Americans with a common and potentially life-threatening form of liver disease will soon have access to the first-ever treatment for … Read more

What’s next in Medicare drug price negotiations

What’s next in Medicare drug price negotiations

Activists protest the price of prescription drug costs in front of the U.S. Department of Health and Human Services building in Washington, D.C., on Oct. 6, 2022. Anna Moneymaker | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good morning! The bitter legal battle … Read more